Trading Paradigm

Train and Develop Professional-Level Trading Skills

  • ARTICLES
  • FREE COURSE
  • TOP RATED
    • #1 Mindset Course
      • 2ndSkies Trading
    • #1 Funding Program
      • Topstep Futures
    • #1 Futures Broker
      • Edge Clear
    • #1 Stock Newsfeed
      • Benzinga Pro
    • #1 Stock Screener
      • Finviz
    • Recommended Books
  • FAQ
  • TRUTH/REALITIES
    • The Fantasy Gap
    • Proper Expectations
    • Knowledge vs. Skills
    • Entertainment vs. Training
    • Trading vs. Gambling
  • MINDSET/PSYCHOLOGY
    • Natural Biases
    • The Mirror Concept
    • Self-Transformation
    • Failure is Feedback
    • More Mindset Articles
  • EDGE/EXPECTED VALUE
    • Market Methodology
    • Expected Value Formula
    • Asymmetric Risk-Reward
    • Trade Tracking & Review
    • More Edge Articles
  • FREE RESOURCES
  • FREE COURSE: TRADING SUCCESS FRAMEWORK → GET STARTED BECOMING A REAL TRADER

What is an Adcom?

February 4, 2017 By Matt Thomas Leave a Comment


Adcom = Advisory Committee

An Advisory Committee is relevant to companies within the biotechnology/pharmaceutical space. For those that don’t know the process of taking drugs to market, it can generally be broken down into stages. First is the preclinical phase, which typically involves the discovery of a promising agent and testing it on live animals (usually rodents). The results of In Vivo Testing are used to demonstrate the safety of the proposed drug in the Investigational New Drug (IND) application that is filed with the Food and Drug Administration (FDA). If the FDA approves the application, the stage is set for phase 1 clinical trials.

As the safety and effectiveness of the drug are tested and proven in humans, the drug can potentially progress from phase 1 to phase 2 and phase 3. If the drug is found to be ineffective, unsafe, or have intolerable side effects at any point throughout these phases, it can be discontinued. If a drug survives phase 1, 2 & 3 clinical trials, then a New Drug Application (NDA) is submitted to the FDA. Upon receipt of the NDA, the FDA completes an independent review and makes any necessary recommendations. This is where an Advisory Committee (Adcom) can come into play, which involves a panel of experts coming together at the FDA’s request to review various aspects of the drug, including (but not limited to) the trial results. Ultimately, the FDA has the final say in approval or rejection.

Related Page: BioPharmCatalyst Review – A Database of Opportunities For Biotech Traders

Filed Under: The Daily Dose: Questions For Stock Traders

TRADING SUCCESS FRAMEWORK (FREE COURSE)

SEARCH

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

TRADING SUCCESS FRAMEWORK (FREE COURSE)

SEARCH

#1 Beginner Learning Program

Thomas Kralow Trading Academy - University Grade Trading Education

Read Full Thomas Kralow Review

#1 Trading Psychology Course

2ndSkies Trading With Chris Capre

Read Full 2ndSkies Trading Review

#1 Funded Futures Trader Program

Topstep Trader - Top Funded Futures Trading Program

Read Full Topstep Trader Review

#1 Stock Market Newsfeed

Benzinga Pro - Top Rated Stock Market Newsfeed

Read Full Benzinga Pro Review

#1 Futures Brokerage Service

What is EdgeClear - Is it the Best Broker to Trade Futures With?

Read Full Edge Clear Review

#1 Stock Screener Tool

Finviz and Finviz Elite - Top Rated Stock Screener

Read Full Finviz Elite Review

Risk Disclaimer||Affiliate Disclosure||Privacy Policy||Site Map||Contact||About